Phase I/II Trial of Epacadostat, Intralesional SD101, Radiotherapy in Patients With Lymphoma

Conditions:   Advanced Solid Tumors;   Lymphoma
Interventions:   Drug: epacadostat;   Drug: SD-101;   Radiation: Radiotherapy
Sponsor:   University of California, Davis
Not yet recruiting

http://ift.tt/2z80qOJ